Parkinson's Disease Proteomic Associations to Clinical Translation

PD-PACT Candidate Nomination

Nominate a protein or protein signature for review by the PD-PACT committee

0 of 0 required answers completeDraft saved in this browser
Demo version. Nominations are downloaded to your computer, not submitted. A live version with secure submission will open when the project begins.
About this form. Each section maps to one of the four requirements a candidate must meet before full review. The panel on the right updates as you go. It takes about 20 minutes. Fields marked * are required, and everything else helps the committee start scoring sooner. Your draft is saved in this browser until you download it. If you prefer not to use the online form, email the project manager, who will complete it with you.
A

About the nomination

Where does this nomination come from? *
Do you have any link to this candidate? *

For example, you authored the key studies, hold a patent, or have a commercial interest. This does not affect eligibility. Committee members with a link step aside from scoring it.

Has PD-PACT reviewed this candidate for the same use before? *
B

The candidate

Requirement 1 · clearly defined
Is this a single protein or a signature? *

A signature is two or more proteins combined into one result by a fixed formula, sometimes with other inputs such as age or sex.

For example phosphorylated, aggregated, a fragment, or a particular isoform. Leave blank if unknown.

Sample type *
C

The intended use

Requirement 2 · one specific use
What would the test be used for? *

Choose one. To nominate the same candidate for a second use, submit a separate form.

D

The evidence

Requirements 3 and 4
Key studies *

List up to five studies, starting with the strongest. At least one should report a difference that stays significant after correcting for the number of proteins tested.

Has the finding been reproduced in a second, independent cohort? optional

This is not an entry requirement. The committee scores replication directly, under criterion 1D.

How can the committee access the evidence? *
E

Committee use only

Completed at intake by the chair and co-chair
Could a fluid protein test plausibly inform this decision?

Draft form for illustration. The PD-PACT committee will refine the questions during the setup phase. Nomination windows open in months 3, 8, 14 and 20 of the project. The intake check on this page is a guide only, and the chair and co-chair make the final decision. If you prefer not to use the online form, email the project manager, who will complete it with you.